United States Afatinib Market Report 2018
- QYR2460771
- 104 Pages
- February 2018
- Materials and Chemicals
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Afatinib in these regions, from 2013 to 2025 (forecast).
United States Afatinib market competition by top manufacturers/players, with Afatinib sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Boehringer Ingelheim
Teva Pharmaceutical Industries
Myosynth
Reva Pharma
Tianjin Scipharmacn
Hubei Purple Sakura Chemical
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
?98%
?98%
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Non-Small Cell Lung Cancer
Application 2
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Afatinib Market Report 2018
1 Afatinib Overview
1.1 Product Overview and Scope of Afatinib
1.2 Classification of Afatinib by Product Category
1.2.1 United States Afatinib Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Afatinib Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 ?98%
1.2.4 ?98%
1.3 United States Afatinib Market by Application/End Users
1.3.1 United States Afatinib Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Non-Small Cell Lung Cancer
1.3.2 Application 2
1.4 United States Afatinib Market by Region
1.4.1 United States Afatinib Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Afatinib Status and Prospect (2013-2025)
1.4.3 Southwest Afatinib Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Afatinib Status and Prospect (2013-2025)
1.4.5 New England Afatinib Status and Prospect (2013-2025)
1.4.6 The South Afatinib Status and Prospect (2013-2025)
1.4.7 The Midwest Afatinib Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Afatinib (2013-2025)
1.5.1 United States Afatinib Sales and Growth Rate (2013-2025)
1.5.2 United States Afatinib Revenue and Growth Rate (2013-2025)
2 United States Afatinib Market Competition by Players/Suppliers
2.1 United States Afatinib Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Afatinib Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Afatinib Average Price by Players/Suppliers (2013-2018)
2.4 United States Afatinib Market Competitive Situation and Trends
2.4.1 United States Afatinib Market Concentration Rate
2.4.2 United States Afatinib Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Afatinib Manufacturing Base Distribution, Sales Area, Product Type
3 United States Afatinib Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Afatinib Sales and Market Share by Region (2013-2018)
3.2 United States Afatinib Revenue and Market Share by Region (2013-2018)
3.3 United States Afatinib Price by Region (2013-2018)
4 United States Afatinib Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Afatinib Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Afatinib Revenue and Market Share by Type (2013-2018)
4.3 United States Afatinib Price by Type (2013-2018)
4.4 United States Afatinib Sales Growth Rate by Type (2013-2018)
5 United States Afatinib Sales (Volume) by Application (2013-2018)
5.1 United States Afatinib Sales and Market Share by Application (2013-2018)
5.2 United States Afatinib Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Afatinib Players/Suppliers Profiles and Sales Data
6.1 Boehringer Ingelheim
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Afatinib Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Boehringer Ingelheim Afatinib Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Teva Pharmaceutical Industries
6.2.2 Afatinib Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Teva Pharmaceutical Industries Afatinib Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Myosynth
6.3.2 Afatinib Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Myosynth Afatinib Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Reva Pharma
6.4.2 Afatinib Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Reva Pharma Afatinib Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Tianjin Scipharmacn
6.5.2 Afatinib Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Tianjin Scipharmacn Afatinib Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Hubei Purple Sakura Chemical
6.6.2 Afatinib Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Hubei Purple Sakura Chemical Afatinib Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
...
7 Afatinib Manufacturing Cost Analysis
7.1 Afatinib Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Afatinib
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Afatinib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Afatinib Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Afatinib Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Afatinib Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Afatinib Sales Volume Forecast by Type (2018-2025)
11.3 United States Afatinib Sales Volume Forecast by Application (2018-2025)
11.4 United States Afatinib Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Figure Product Picture of Afatinib
Figure United States Afatinib Market Size (K Units) by Type (2013-2025)
Figure United States Afatinib Sales Volume Market Share by Type (Product Category) in 2017
Figure ?98% Product Picture
Figure ?98% Product Picture
Figure United States Afatinib Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Afatinib by Application in 2017
Figure Non-Small Cell Lung Cancer Examples
Table Key Downstream Customer in Non-Small Cell Lung Cancer
Table Key Downstream Customer in Application 2
Figure United States Afatinib Market Size (Million USD) by Region (2013-2025)
Figure The West Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Afatinib Sales (K Units) and Growth Rate (2013-2025)
Figure United States Afatinib Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Afatinib Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Afatinib Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Afatinib Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Afatinib Sales Share by Players/Suppliers
Figure 2017 United States Afatinib Sales Share by Players/Suppliers
Figure United States Afatinib Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Afatinib Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Afatinib Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Afatinib Revenue Share by Players/Suppliers
Figure 2017 United States Afatinib Revenue Share by Players/Suppliers
Table United States Market Afatinib Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Afatinib Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Afatinib Market Share of Top 3 Players/Suppliers
Figure United States Afatinib Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Afatinib Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Afatinib Product Category
Table United States Afatinib Sales (K Units) by Region (2013-2018)
Table United States Afatinib Sales Share by Region (2013-2018)
Figure United States Afatinib Sales Share by Region (2013-2018)
Figure United States Afatinib Sales Market Share by Region in 2017
Table United States Afatinib Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Afatinib Revenue Share by Region (2013-2018)
Figure United States Afatinib Revenue Market Share by Region (2013-2018)
Figure United States Afatinib Revenue Market Share by Region in 2017
Table United States Afatinib Price (USD/Unit) by Region (2013-2018)
Table United States Afatinib Sales (K Units) by Type (2013-2018)
Table United States Afatinib Sales Share by Type (2013-2018)
Figure United States Afatinib Sales Share by Type (2013-2018)
Figure United States Afatinib Sales Market Share by Type in 2017
Table United States Afatinib Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Afatinib Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Afatinib by Type (2013-2018)
Figure Revenue Market Share of Afatinib by Type in 2017
Table United States Afatinib Price (USD/Unit) by Types (2013-2018)
Figure United States Afatinib Sales Growth Rate by Type (2013-2018)
Table United States Afatinib Sales (K Units) by Application (2013-2018)
Table United States Afatinib Sales Market Share by Application (2013-2018)
Figure United States Afatinib Sales Market Share by Application (2013-2018)
Figure United States Afatinib Sales Market Share by Application in 2017
Table United States Afatinib Sales Growth Rate by Application (2013-2018)
Figure United States Afatinib Sales Growth Rate by Application (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Afatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Afatinib Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Afatinib Sales Market Share in United States (2013-2018)
Figure Boehringer Ingelheim Afatinib Revenue Market Share in United States (2013-2018)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Afatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Pharmaceutical Industries Afatinib Sales Growth Rate (2013-2018)
Figure Teva Pharmaceutical Industries Afatinib Sales Market Share in United States (2013-2018)
Figure Teva Pharmaceutical Industries Afatinib Revenue Market Share in United States (2013-2018)
Table Myosynth Basic Information List
Table Myosynth Afatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Myosynth Afatinib Sales Growth Rate (2013-2018)
Figure Myosynth Afatinib Sales Market Share in United States (2013-2018)
Figure Myosynth Afatinib Revenue Market Share in United States (2013-2018)
Table Reva Pharma Basic Information List
Table Reva Pharma Afatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Reva Pharma Afatinib Sales Growth Rate (2013-2018)
Figure Reva Pharma Afatinib Sales Market Share in United States (2013-2018)
Figure Reva Pharma Afatinib Revenue Market Share in United States (2013-2018)
Table Tianjin Scipharmacn Basic Information List
Table Tianjin Scipharmacn Afatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Tianjin Scipharmacn Afatinib Sales Growth Rate (2013-2018)
Figure Tianjin Scipharmacn Afatinib Sales Market Share in United States (2013-2018)
Figure Tianjin Scipharmacn Afatinib Revenue Market Share in United States (2013-2018)
Table Hubei Purple Sakura Chemical Basic Information List
Table Hubei Purple Sakura Chemical Afatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hubei Purple Sakura Chemical Afatinib Sales Growth Rate (2013-2018)
Figure Hubei Purple Sakura Chemical Afatinib Sales Market Share in United States (2013-2018)
Figure Hubei Purple Sakura Chemical Afatinib Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Afatinib
Figure Manufacturing Process Analysis of Afatinib
Figure Afatinib Industrial Chain Analysis
Table Raw Materials Sources of Afatinib Major Players/Suppliers in 2017
Table Major Buyers of Afatinib
Table Distributors/Traders List
Figure United States Afatinib Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Afatinib Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Afatinib Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Afatinib Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Afatinib Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Afatinib Sales Volume (K Units) Forecast by Type in 2025
Table United States Afatinib Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Afatinib Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Afatinib Sales Volume (K Units) Forecast by Application in 2025
Table United States Afatinib Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Afatinib Sales Volume Share Forecast by Region (2018-2025)
Figure United States Afatinib Sales Volume Share Forecast by Region (2018-2025)
Figure United States Afatinib Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Photonic Crystals are attractive optical materials for controlling and manipulating the flow of light. The global market for components and modules using Photonic Crystals indicates a CAGR of 33.1% and is estimated to reach $20.4 billion in 2017.
Nanomaterials possess nanoscale dimensions ranging from 1 to 100 nanometers. They occur naturally or can be engineered with specific properties such as size, shape, surface, and chemistry. Volcanic ash and forest fibers are some of the examples of natural nano...
- Publish Date: September 10, 2016
- $5820
Global molded plastics market was valued at $529,845 million in 2016, and is expected to garner $690,158 million by 2023, registering a CAGR of 3.9% from 2017 to 2023. Molded plastics are synthetically produced non-metallic compounds, which can be molded ...
- Publish Date: July 4, 2017
- $5370
